Verastem Inc (NASDAQ:VSTM)

9.44
BATS BZX Real-Time Price
As of 12:09pm ET
 -0.21 / -2.18%
Today’s Change
3.47
Today|||52-Week Range
15.18
+95.45%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$244.9M

Company Description

Verastem, Inc. is a biopharmaceutical company, which engages in the development and commercialization of drugs for the treatment of cancer. The company was founded by Richard H. Aldrich, Michelle Dipp, Piyush Gupta, Satish Jindal, Eric S. Lander, Robert F. Weinberg, and Christoph H. Westphal on August 4, 2010 and is headquartered in Needham, MA.

Contact Information

Verastem, Inc.
117 Kendrick Street
Needham Massachusetts 02494
P:(781) 292-4200
Investor Relations:

Employees

Shareholders

Other institutional30.10%
Mutual fund holders13.88%
Individual stakeholders0.93%

Top Executives

Dan PatersonPresident, Chief Executive Officer & Director
Daniel CalkinsVP, Chief Financial & Accounting Officer
Jonathan PachterChief Scientific Officer
Louis J. DenisChief Medical Officer
Hagop YoussoufianHead-Medical Strategy